Correction to “Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major”

IF 2.4 3区 医学 Q2 HEMATOLOGY
{"title":"Correction to “Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major”","authors":"","doi":"10.1002/pbc.31411","DOIUrl":null,"url":null,"abstract":"<p>Jian X, Liu X, Peng W, Li L, Hua F, Chen K, Zhang J, Luo S, Yang K, Wu Y. Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major. Pediatr Blood Cancer. 2023 Apr 28:e30391. https://doi.org/10.1002/pbc.30391.</p><p>The affiliation “Department of Hematology, West China Hospital, Chengdu, China” should be corrected to “Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.”</p><p>Due to an oversight, the affiliation is incomplete for author Yu Wu.</p><p>The author byline and correspondence sections should read:</p><p>Jian Xiao<sup>1,2</sup>, Xiaodong Liu<sup>2</sup>, Wei Peng<sup>2</sup>, Lan Li<sup>2</sup>, Fang Hua<sup>2</sup>, Kun Chen<sup>2</sup>, Jin Zhang<sup>2</sup>, Shan Luo<sup>2</sup>, Kun Yang<sup>2*</sup>, Yu Wu<sup>1*</sup></p><p><sup>1</sup>Department of Hematology, West China Hospital, Sichuan University, Chengdu, China;</p><p><sup>2</sup>Department of Hematology, Zigong First People's Hospital, Zigong, China</p><p><sup>*</sup> Correspondence to:</p><p>Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China; E-mail: [email protected]</p><p>Yu Wu, Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China, E-mail: [email protected]</p><p>We apologize for this error.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":"72 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31411","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31411","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Jian X, Liu X, Peng W, Li L, Hua F, Chen K, Zhang J, Luo S, Yang K, Wu Y. Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major. Pediatr Blood Cancer. 2023 Apr 28:e30391. https://doi.org/10.1002/pbc.30391.

The affiliation “Department of Hematology, West China Hospital, Chengdu, China” should be corrected to “Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.”

Due to an oversight, the affiliation is incomplete for author Yu Wu.

The author byline and correspondence sections should read:

Jian Xiao1,2, Xiaodong Liu2, Wei Peng2, Lan Li2, Fang Hua2, Kun Chen2, Jin Zhang2, Shan Luo2, Kun Yang2*, Yu Wu1*

1Department of Hematology, West China Hospital, Sichuan University, Chengdu, China;

2Department of Hematology, Zigong First People's Hospital, Zigong, China

* Correspondence to:

Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China; E-mail: [email protected]

Yu Wu, Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China, E-mail: [email protected]

We apologize for this error.

更正 "沙利度胺治疗重型β地中海贫血患儿的长期疗效和安全性"。
Jian X, Liu X, Peng W, Li L, Hua F, Chen K, Zhang J, Luo S, Yang K, Wu Y.沙利度胺治疗重型β地中海贫血患儿的长期疗效和安全性。Pediatr Blood Cancer.2023 Apr 28:e30391. https://doi.org/10.1002/pbc.30391作者单位 "中国成都华西医院血液科 "应更正为 "中国成都四川大学华西医院血液科"。由于疏忽,作者Yu Wu的单位不完整。作者署名和通讯作者应为:肖健1,2, 刘晓东2, 彭伟2, 李岚2, 华芳2, 陈坤2, 张瑾2, 罗珊2, 杨坤2*, 吴瑜1*1四川大学华西医院血液科,中国成都;2自贡市第一人民医院血液科,中国自贡* 通讯作者:四川大学华西医院血液科杨坤:杨坤,自贡市第一人民医院血液科,自贡,643000;E-mail:[email protected]Yu Wu,四川大学华西医院血液科,成都,610041;E-mail:[email protected]我们对此错误深表歉意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Blood & Cancer
Pediatric Blood & Cancer 医学-小儿科
CiteScore
4.90
自引率
9.40%
发文量
546
审稿时长
1.5 months
期刊介绍: Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信